Insulin-like growth factors in childhood-onset Gaucher disease

Pediatric Research

Volumn 52, Issue 1, 2002, Pages 109-112

  Rite, Segundo ^a,d,e   Baldellou, Antonio ^a,d   Giraldo, Pilar ^a,d   Labarta, Jose Ignacio ^a   Giralt, Manuel ^a,d   Rubio Félix, Daniel ^a,d   Guallar, Ana ^a   Pérez Calvo, Jose Ignacio ^b,d   Mayayo, Esteban ^a   Ferrández, Angel ^a   Pocovi, Miguel ^c,d  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d FEETEG (Spanish Foundation for the Study and Treatment of Gaucher Disease)   (Spain)

^e NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ANALYTICAL PARAMETERS; ARTICLE; BODY GROWTH; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; GENE MUTATION; GROWTH RETARDATION; HUMAN; LABORATORY TEST; LIVER DISEASE; MALE; MEASUREMENT; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; RANK SUM TEST; SCORING SYSTEM; STATISTICAL ANALYSIS;

EID: 0036086956     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200207000-00020     Document Type: Article

References (27)

1. Gaucher disease
2. Genetic fine localization of the beta-glucocerebrosidase (GBA) and prosaposin (PSAP) genes: Implications for Gaucher disease
3. Glucocerebrosidase mutations in Gaucher disease
4. Genotype/phenotype correlations in Gaucher's disease
5. Gaucher's disease: Clinical features and natural history
6. Maladie de Gaucher
7. Gaucher disease: Studies of phenotype, molecular diagnosis and treatment
8. A practical approach to diagnosis and management of Gaucher's disease
9. Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase
10. The endocrine role of insulin-like growth factor I
11. Growth hormone and insulin-like growth factor I as anabolic agents
12. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children
13. Immunoblot studies of the acid labile subunit (ALS) in biological fluids, normal human serum and in children with GH deficiency and GH receptor deficiency before and after long term therapy with GH or IGF-I respectively
14. Nutritional regulation of the insulin-like growth factors
15. Effects of caloric or protein restriction on insulin-like growth factor 1 (IGF-I) and IGF binding proteins in children and adults
16. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1,2, and 3 in children with chronic renal failure: Relationship to height and glomerular filtration rate
17. Prediction of severity of Gaucher's disease by identification of mutations at DNA level
18. Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease
19. A simple salting out procedure for extracting DNA from human nucleated cells
20. β-glucocerebrosidase gene locus as a link for Gaucher's disease and familial hypo-a-lipoproteinaemia
21. The facile detection of the nt 1226 mutation of glucocerebrosidase by mismatched PCR
22. Use of denaturing gradient gel electrophoresis to identify mutant sequences in the beta-glucocerebrosidase gene
23. New Gaucher disease mutations in exon 10; a novel L444R mutation produces a new Ncil site the same as L444P
24. Erroneous assignment of Gaucher disease genotype as consequence of a gene deletion
25. Delayed growth and puberty in patients with Gaucher disease type 1: Natural history and effect of splenectomy and/or enzyme replacement therapy
26. Genetic diagnosis of Gaucher's disease
27. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults